The Trump administration begins with exemptions at CDC, FDA and other health agencies

The Trump administration begins with exemptions at CDC, FDA and other health agencies

Hundreds of federal healthcare workers, including doctors in higher managerial positions, began to hear early on Tuesday morning that they lose their jobs, some of the huge restructuring, which will refer the agencies responsible for regulating food and drugs, protecting Americans against diseases and studying up-to-date methods of treatment and treatment.

Secretary of Health Robert F. Kennedy Jr. He announced last week that he was reduced by 10,000 employees. Employees say that some older leaders based in Washington received notifications that they were again assigned to the Indian territories of health care, the tactics of forcing people, because it entails moving to other parts of the country.

In conjunction with previous departures, the dismissal will reduce the department from 82,000 to 62,000 employees. The department did not immediately answer the request for comment.

Employees said that notifications began to arrive at 5 am, influencing the offices responsible for everything, from global health, medical devices to communication. Some knew that the exemptions were coming; According to employees at the headquarters of the Main Department in Washington, officials responsible for minority health and prevention of infectious diseases were said on Friday that their offices were eliminated.

Others were surprised. In Food and Drug Administration, older leaders were pushed out, and offices focused on the policy of food, drugs and medical devices were affected by deep personnel reductions by about 3,500 agency employees. Some employees said they discovered that they were released when they tried to scan their badge to get to the building on Tuesday.

According to Mitch Zeller, his predecessor in the division, the best tobacco regulator, Brian King, was offered to work at the Regional Indian Health Service office, which includes Alaska. Other employees who supervise veterinary medicine and coordinate intricate work related to the review of up-to-date exploit of drugs that can act on thousands of pages have been released.

Some Centers for Disease Control and Prevention leaders, including Kayla Laserson, who ran the Global Health Center, received similar notifications about the re -acceptance or were placed on administrative leave. At the reorganization agency, with cuts of a total of 2400, it seemed to be aimed at narrowing the focus on infectious diseases. The entire departments examining chronic diseases and environmental problems have been cut out.

Employees dismissed in the agency included people studying injuries, asthma, lead poisoning, smoking and radiation damage, as well as those who assess the health effects of extreme heat and fires.

But some syndromes of infectious diseases were also released. A group focusing on improving access to vaccines among underestimated communities, like a group of global health researchers who worked on preventing mother to transfer HIV by children

HIV prevention was generally a immense target. Jonathan Mermin, director of the HIV Center and sexually transmitted diseases, was placed on administrative leave. Trump’s administration weighed the transfer of HIV CDC prevention department to another agency in the health department. But on Tuesday, teams leading in HIV supervision and research in this department were released. It was not clear whether some of these functions would be restored elsewhere.

At the National Institutes of Health, several institute directors received notifications of re -admission to the territories of the Indian health service and they were told that they would have to report on Wednesday about whether they would accept this movement.

Among them was Dr. Jeanne Marrazzo, who replaced Dr. Anthony S. Fauci as the director of the National Institute of Allergy and Infectious Diseases and Shannon Zenk, who runs the National Institute of Nursing Research.

Communication offices were particularly strongly hit at agencies, including NIH, CDC and FDA Renate Myles, communication director at the National Institutes of Health, received a notification of a re -permit. Mr. Kennedy, who promised “radical transparency”, said he wanted to consolidate communication under his scope.

HHS “centralizes communication throughout the entire department to provide a more coordinated and effective response to public health challenges, ultimately bringing benefits to an American taxpayer,” said Emily Hilliard, deputy secretary of the press department on Friday.

Leave a Reply

Your email address will not be published. Required fields are marked *